NIRAMAI breast cancer screening test,

Thermalytix, is a computer aided diagnostic engine that is powered by Artificial Intelligence. The solution uses a high resolution thermal sensing device and a cloud hosted analytics solution for analyzing the thermal scans for reliable, early and accurate breast cancer screening.

Thermalytix cancer screening test has been used by more than 200,000 women in 250+ hospitals/diagnostic center as well as 50000+ screening camps in 12 countries. Niramai Thermalytix test has obtained a CE Mark for all European countries and regulatory clearance in many Asian and European countries.

Niramai Quality Management Processes are certified to be compliant with ISO 13485 and MDSAP. We follow good clinical practices, comply with information security and data privacy policies, as per EU GDPR and US HIPAA requirements.

Results of multiple clinical studies comparing Thermalytix with current standard of care have been published in peer reviewed conference/journals. The results from these clinical trials indicate very high accuracy of Thermalytix that is non-inferior to X-Ray Mammography in general, and better sensitivity than mammography in women with dense breasts.

Key Highlights of Niramai test:

1. It is painless and radiation-free
   
2. It is completely privacy-aware i.e. no one touches or sees you while screening
   
3. There are no side effects of the screening and the screening can be done multiple times
4. Thermalytix works for any female above 18 years
   
5. Thermalytix has high accuracy even in dense breast women
6. Thermalytix is a portable test, increases access to care
7. It is also lower cost than traditional techniques
8. Thermalytix generates an instant report using Machine Learning hosted on Azure Cloud Services, ensuring complete data privacy